Abstract
Background
The aim of our study was to present the technique for, and early results of complete laparoscopic pelvic peritonectomy (LPP) plus hyperthermic intraperitoneal chemotherapy (HIPEC).
Methods
We conducted a study on consecutive patients who had LPP for limited peritoneal carcinomatosis (peritoneal carcinomatosis index < 10) from ovarian cancer, colon cancer and benign multicystic mesothelioma, from January 2017 to November 2019 at 2 referral centers in Spain. Perioperative, pathologic, 30-day major morbidity and mortality characteristics were analyzed. The surgical technique is shown in the attached video.
Results
Twelve LPP + HIPEC were performed. Complete cytoreduction was achieved in 100% of the patients, the median duration of the operation was 450 min (range 360–600 min). There were 2 cases (16%) of IIIa morbidity (trocar hernia and pleural effusion), and no mortality. The median length of hospital stay was 5.5 days (range 4–10 days). The median length of follow-up was 10 months (range 2–30 months). There was a recurrence at the splenic hilum in 1 patient which was treated by laparoscopic splenectomy and one nodal recurrence at 13 months while all other patients are alive and free of disease at last follow-up.
Conclusions
This is the first technical video of a minimally invasive approach for complete pelvic peritonectomy plus omentectomy associated with HIPEC. For highly selected patients, this procedure presents a feasible and safe alternative to the maximally invasive approach.
Similar content being viewed by others
References
Foster JM, Sleightholm R, Patel A et al (2019) Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures. JAMA Netw Open 2(1):e186847
Sugarbaker PH (2013) Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy: textbook and video atlas. PSOGI 1:1–22
Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery andhyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 249:900–907
Esquivel J, Averbach A, Chua TC (2011) Laparoscopic cytoreductivesurgery and hyperthermic intraperitoneal chemotherapyin patients with limited peritoneal surface malignancies: feasibility, morbidity and outcome in an early experience. Ann Surg 253:764–768
Passot G, Bakrin N, Isaac S, Decullier E, Gilly FN, Glehen O, Cotte E (2013) Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Eur J Surg Oncol 40:957–962
Arjona-Sanchez A, Esquivel J, Glehen O et al (2019) A minimally invasive approach for peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (HIPEC) in limited peritoneal carcinomatosis: The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution analysis. Surg Endosc 33(3):854–860
Arjona-Sanchez A, Rufian-Peña S, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Briceño-Delgado J (2018) Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (HIPEC) by minimally invasive approach, an initial experience. World J Surg 42(10):3120–3124
Arjona-Sanchez A, Durán M, Sanchez Hidalgo JM, Rufian Peña S (2019) Peritoneal carcinomatosis from ovarian carcinoma treated by interval laparoscopic complete cytoreduction and HIPEC with extraction through natural orifice. Surg Oncol 31:14–15
Gallotta V, Ghezzi F, Vizza E, Fagotti A, Ceccaroni M, Fanfani F, Chiantera V, Ercoli A, Rossitto C, Conte C, Uccella S, Corrado G, Scambia G, Ferrandina G (2016) Laparoscopic management of ovarian cancer patients with localized carcinomatosis and lymph node metastases: results of a retrospective multi-institutional series. J Min Invasive Gynecol 23(4):590–596
Harter P, Sehouli J, Lorusso D et al (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822–832
Sánchez-Hidalgo JM, Rodríguez-Ortiz L, Arjona-Sánchez A et al (2019) Colorectal peritoneal metastases: optimal management review. World J Gastroenterol 25(27):3484–3502
Quenet F, Elias D, Roca L et al (2018) A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7. J Clin Oncol 36:3503
Prada-Villaverde A, Esquivel J, Lowy AM et al (2014) The American Society of Peritoneal Surface Malignancies Evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol 110(7):779–785
Rodríguez-Ortiz L, Arjona-Sánchez A, Ibañez-Rubio M et al (2020) Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Surg Endosc. https://doi.org/10.1007/s00464-020-07572-x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in this study are in accordance with ethical standars. The study has been approved by local Ethics Committees.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary material 1 (MP4 1557637 kb)
Rights and permissions
About this article
Cite this article
Arjona-Sánchez, A., Cortés-Guiral, D., Duran-Martínez, M. et al. Complete laparoscopic pelvic peritonectomy plus hyperthermic intraperitoneal chemotherapy. Tech Coloproctol 24, 1083–1088 (2020). https://doi.org/10.1007/s10151-020-02277-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-020-02277-8